4.7 Article

Biodegradable Copper-Based Nanoparticles Augmented Chemodynamic Therapy through Deep Penetration and Suppressing Antioxidant Activity in Tumors

Journal

ADVANCED HEALTHCARE MATERIALS
Volume 10, Issue 14, Pages -

Publisher

WILEY
DOI: 10.1002/adhm.202100412

Keywords

biodegradation; chemodynamic therapy; copper; glutathione; heme oxygenase

Funding

  1. National Natural Science Foundation of China [21777152, 21573216]
  2. Science and Technology Development Project Foundation of Jilin Province [20200404129YY, YDZJ202101ZYTS108]
  3. Budgeted Capital Construction Fundation of Jilin Province [2020C035-4]

Ask authors/readers for more resources

The CCMZ NPs are designed to enhance CDT efficacy by inhibiting HO-1 activity, depleting GSH, and converting hydrogen peroxide into hydroxyl radical to eliminate tumor cells efficiently.
Chemodynamic therapy (CDT) efficacy has been limited by the poor penetration ability of large nanoparticles (NPs) and the antioxidant activity of tumors, especially high heme oxygenase (HO-1) and glutathione (GSH) levels. Herein, PEGylated CuMoOx-coated and zinc protoporphyrin IX (ZP)-loaded Cu (CCMZ) NPs are designed to afford rapid degradation ability and augmented CDT efficacy through inhibiting HO-1 activity and depleting GSH. The deep penetration of tumor can be achieved under the high levels of GSH, which triggers the degradation of CuMoOx shell. Meanwhile, GSH itself is depleted, which converts the reductive environment into constant oxidative environment, thus leading to the degradation of Cu core. Furthermore, the release of ZP from CCMZ NPs can inhibit HO-1 activity and provide a favorable microenvironment for CDT, and the release of Cu and Mo ions can convert hydrogen peroxide into hydroxyl radical to eliminate tumor cells more efficiently. In addition, CCMZ NPs also play an immune vaccine-like effect to recruit different immune cells for antitumor immunotherapy. In vitro and in vivo studies prove the augmented CDT property of CCMZ NPs, supplying a new strategy for improving CDT efficacy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available